2012

Mar

Constellation Pharmaceuticals Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer

Posted in Constellation in the News, Newsroom

Mark A. Goldsmith, M.D., Ph.D., to Serve as Executive Chairman of the Board of Directors CAMBRIDGE, Mass. – March 27, 2012 – Constellation Pharmaceuticals, Inc., a leading biopharmaceutical company in the field of epigenetics, today announced the appointment of Keith E. Dionne, Ph.D., to the role of president and chief executive officer to succeed Mark [...]

Jan

Constellation Pharmaceuticals and Genentech Enter Broad Epigenetics Drug Discovery Collaboration

Posted in Constellation in the News, Newsroom

CAMBRIDGE, Mass. – January 17, 2012 – Constellation Pharmaceuticals, Inc., today announced that it has entered into a major strategic agreement with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), to launch a broad collaboration based on the science of epigenetics and chromatin biology to discover and develop innovative treatments for [...]